Importance of circulating IGF-1 for normal cardiac morphology, function and post infarction remodeling

Growth Hormone and IGF Research

Volumn 22, Issue 6, 2012, Pages 206-211

  Täng, M Scharin ^a   Redfors, B ^a   Lindbom, M ^a   Svensson, J ^b   Ramunddal, T ^a   Ohlsson, C ^b   Shao, Y ^a   Omerovic, E ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Creatine; Echocardiography; Heart failure; Insulin like growth factor 1 (IGF 1); Myocardial infarction

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CREATINE; CREATINE PHOSPHATE; DOBUTAMINE; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FUNCTIONAL MORPHOLOGY; GENE DELETION; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE; HIGH ENERGY PHOSPHATE; IGF 1 GENE; METABOLIC REGULATION; MOUSE; NONHUMAN; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; REST; TRANSTHORACIC ECHOCARDIOGRAPHY;

ANIMALS; DISEASE MODELS, ANIMAL; HEART VENTRICLES; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIUM; PHOSPHOCREATINE; VENTRICULAR REMODELING;

EID: 84868454231     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2012.09.002     Document Type: Article

References (34)

1. Turer A.T., Malloy C.R., Newgard C.B., Podgoreanu M.V. Energetics and metabolism in the failing heart: important but poorly understood. Curr. Opin. Clin. Nutr. Metab. Care 2010, 13:458-465.
2. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990, 81:1161-1172.
3. Ren J., Samson W.K., Sowers J.R. Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. J. Mol. Cell. Cardiol. 1999, 31:2049-2061.
4. Watanabe S., Tamura T., Ono K., Horiuchi H., Kimura T., Kita T., Furukawa Y. Insulin-like growth factor axis (insulin-like growth factor-I/insulin-like growth factor-binding protein-3) as a prognostic predictor of heart failure: association with adiponectin. Eur. J. Heart Fail. 2010, 12:1214-1222.
5. Anker S.D., Volterrani M., Pflaum C.D., Strasburger C.J., Osterziel K.J., Doehner W., Ranke M.B., Poole-Wilson P.A., Giustina A., Dietz R., Coats A.J. Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J. Am. Coll. Cardiol. 2001, 38:443-452.
6. Andreassen M., Kistorp C., Raymond I., Hildebrandt P., Gustafsson F., Kristensen L.O., Faber J. Plasma insulin-like growth factor I as predictor of progression and all cause mortality in chronic heart failure. Growth Horm. IGF Res. 2009, 19:486-490.
7. Tivesten A., Caidahl K., Kujacic V., Sun X.Y., Hedner T., Bengtsson B.A., Isgaard J. Similar cardiovascular effects of growth hormone and insulin-like growth factor-I in rats after experimental myocardial infarction. Growth Horm. IGF Res. 2001, 11:187-195.
8. Kinugawa S., Tsutsui H., Ide T., Nakamura R., Arimura K., Egashira K., Takeshita A. Positive inotropic effect of insulin-like growth factor-1 on normal and failing cardiac myocytes. Cardiovasc. Res. 1999, 43:157-164.
9. Feinberg M.S., Scheinowitz M., Laron Z. Echocardiographic dimensions and function in adults with primary growth hormone resistance (Laron syndrome). Am. J. Cardiol. 2000, 85:209-213.
10. Laron Z. Insulin-like growth factor-I (lGF-l): safety and efficacy. Pediatr. Endocrinol. Rev. 2004, 2(Suppl. 1):78-85.
11. Sjogren K., Liu J.L., Blad K., Skrtic S., Vidal O., Wallenius V., LeRoith D., Tornell J., Isaksson O.G.P., Jansson J.O., Ohlsson C. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:7088-7092.
12. ten Hove M., Makinen K., Sebag-Montefiore L., Hunyor I., Fischer A., Wallis J., Isbrandt D., Lygate C., Neubauer S. Creatine uptake in mouse hearts with genetically altered creatine levels. J. Mol. Cell. Cardiol. 2008, 45:453-459.
13. Ten Hove M., Chan S., Lygate C., Monfared M., Boehm E., Hulbert K., Watkins H., Clarke K., Neubauer S. Mechanisms of creatine depletion in chronically failing rat heart. J. Mol. Cell. Cardiol. 2005, 38:309-313.
14. Horn M., Remkes H., Dienesch C., Hu K., Ertl G., Neubauer S. Chronic high-dose creatine feeding does not attenuate left ventricular remodeling in rat hearts post-myocardial infarction. Cardiovasc. Res. 1999, 43:117-124.
15. Omerovic E., Bollano E., Lorentzon M., Walser M., Mattsson-Hulten L., Isgaard J. Growth hormone induces myocardial expression of creatine transporter and decreases plasma levels of IL-1beta in rats during early postinfarct cardiac remodeling. Growth Horm. IGF Res. 2003, 13:239-245.
16. Odoom J.E., Kemp G.J., Radda G.K. The regulation of total creatine content in a myoblast cell line. Mol. Cell. Biochem. 1996, 158:179-188.
17. Sjogren K., Jansson J.O., Isaksson O.G., Ohlsson C. A model for tissue-specific inducible insulin-like growth factor-I (IGF-I) inactivation to determine the physiological role of liver-derived IGF-I. Endocrine 2002, 19:249-256.
18. Selye H., Bajusz E., Grasso S., Mendell P. Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology 1960, 11:398-407.
19. Kumar D., Hacker T.A., Buck J., Whitesell L.F., Kaji E.H., Douglas P.S., Kamp T.J. Distinct mouse coronary anatomy and myocardial infarction consequent to ligation. Coron. Artery Dis. 2005, 16:41-44.
20. Aurigemma G.P., Gaasch W.H., Villegas B., Meyer T.E. Noninvasive assessment of left ventricular mass, chamber volume, and contractile function. Curr. Probl. Cardiol. 1995, 20:361-440.
21. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
22. Soussi B., Lagerwall K., Idstrom J.P., Schersten T. Purine metabolic pathways in rat hindlimb perfusion model during ischemia and reperfusion. Am. J. Physiol. 1993, 265:H1074-H1081.
23. Ito H., Hiroe M., Hirata Y., Tsujino M., Adachi S., Shichiri M., Koike A., Nogami A., Marumo F. Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation 1993, 87:1715-1721.
24. Ren J., Brown-Borg H.M. Impaired cardiac excitation-contraction coupling in ventricular myocytes from Ames dwarf mice with IGF-I deficiency. Growth Horm. IGF Res. 2002, 12:99-105.
25. Ross J. Growth hormone, cardiomyocyte contractile reserve, and heart failure. Circulation 1999, 99:15-17.
26. Omerovic E., Bollano E., Mobini R., Kujacic V., Madhu B., Soussi B., Fu M., Hjalmarson A., Waagstein F., Isgaard J. Growth hormone improves bioenergetics and decreases catecholamines in postinfarct rat hearts. Endocrinology 2000, 141:4592-4599.
27. Saetrum Opgaard O., Wang P.H. IGF-I is a matter of heart. Growth Horm. IGF Res. 2005, 15:89-94.
28. McGuire D.M., Tormanen C.D., Segal I.S., Van Pilsum J.F. The effect of growth hormone and thyroxine on the amount of L-arginine:glycine amidinotransferase in kidneys of hypophysectomized rats. Purification and some properties of rat kidney transamidinase. J. Biol. Chem. 1980, 255:1152-1159.
29. Horn M., Remkes H., Stromer H., Dienesch C., Neubauer S. Chronic phosphocreatine depletion by the creatine analogue beta-guanidinopropionate is associated with increased mortality and loss of ATP in rats after myocardial infarction. Circulation 2001, 104:1844-1849.
30. Tivesten A., Bollano E., Andersson I., Fitzgerald S., Caidahl K., Sjogren K., Skott O., Liu J.L., Mobini R., Isaksson O.G., Jansson J.O., Ohlsson C., Bergstrom G., Isgaard J. Liver-derived insulin-like growth factor-I is involved in the regulation of blood pressure in mice. Endocrinology 2002, 143:4235-4242.
31. Pete G., Hu Y., Walsh M., Sowers J., Dunbar J.C. Insulin-like growth factor-I decreases mean blood pressure and selectively increases regional blood flow in normal rats. Proc. Soc. Exp. Biol. Med. 1996, 213:187-192.
32. Honsho S., Nishikawa S., Amano K., Zen K., Adachi Y., Kishita E., Matsui A., Katsume A., Yamaguchi S., Nishikawa K., Isoda K., Riches D.W., Matoba S., Okigaki M., Matsubara H. Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways. Circ. Res. 2009, 105:1149-1158.
33. Cittadini A., Grossman J.D., Stromer H., Katz S.E., Morgan J.P., Douglas P.S. Importance of an intact growth hormone/insulin-like growth factor 1 axis for normal post-infarction healing: studies in dwarf rats. Endocrinology 2001, 142:332-338.
34. Lee W.L., Chen J.W., Ting C.T., Lin S.J., Wang P.H. Changes of the insulin-like growth factor I system during acute myocardial infarction: implications on left ventricular remodeling. J. Clin. Endocrinol. Metab. 1999, 84:1575-1581.